• Profile
Close

Inhaled corticosteroids in ventilated preterm neonates: A non-randomized dose-ranging study

BMC Pediatrics May 11, 2018

Raghuram k, et al. - A non-randomized dose-ranging trial was performed to determine an effective dose of inhaled corticosteroids (ICS) for the treatment of ventilator-dependent infants to facilitate extubation or reduce fractional inspired oxygen concentration. This research was conducted on 41 infants born at < 32 weeks gestational age (GA) or < 1250 g who were ventilator-dependent at 10–28 days postnatal age. They discovered that therapeutic efficacy was not achieved with all studied doses of ICS, however, a significant reduction in oxygen requirements was noted in ventilator-dependent preterm infants at 10–28 days of age when given 800 μg of hydrofluoralkane beclomethasone dipropionate (HFA-BDP) bid.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay